CN105055431B - 一种具有抗结核菌的药物及其应用 - Google Patents
一种具有抗结核菌的药物及其应用 Download PDFInfo
- Publication number
- CN105055431B CN105055431B CN201510490616.6A CN201510490616A CN105055431B CN 105055431 B CN105055431 B CN 105055431B CN 201510490616 A CN201510490616 A CN 201510490616A CN 105055431 B CN105055431 B CN 105055431B
- Authority
- CN
- China
- Prior art keywords
- phosphoiodyns
- tubercle bacillus
- compound
- tulase
- concentration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510490616.6A CN105055431B (zh) | 2015-08-11 | 2015-08-11 | 一种具有抗结核菌的药物及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510490616.6A CN105055431B (zh) | 2015-08-11 | 2015-08-11 | 一种具有抗结核菌的药物及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105055431A CN105055431A (zh) | 2015-11-18 |
CN105055431B true CN105055431B (zh) | 2018-03-13 |
Family
ID=54485116
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510490616.6A Expired - Fee Related CN105055431B (zh) | 2015-08-11 | 2015-08-11 | 一种具有抗结核菌的药物及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105055431B (zh) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19843222A1 (de) * | 1998-09-22 | 2000-03-30 | Hassan Jomaa | Verwendung von phosphororganischen Verbindungen zur therapeutischen und prophylaktischen Behandlung von Infektionen |
-
2015
- 2015-08-11 CN CN201510490616.6A patent/CN105055431B/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN105055431A (zh) | 2015-11-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2013135192A1 (zh) | 百秋李醇的新用途 | |
Odeleye et al. | Evaluation of preliminary phytochemical and antibacterial activity of Ageratum conyzoides (L.) on some clinical bacterial isolates | |
Emmanuel et al. | Antimicrobial activity of Zingiber officinale and Allium sativum on some drug resistant bacterial isolates | |
CN105055431B (zh) | 一种具有抗结核菌的药物及其应用 | |
CN107865849A (zh) | Apigenin在制备治疗抗结核菌药物中的应用 | |
CN105250270A (zh) | Cyanogramide在制备抗结核菌药物中的应用 | |
CN107837255A (zh) | Isovitexin在制备治疗抗结核菌药物中的应用 | |
CN107837259A (zh) | Orientin在制备治疗抗结核菌药物中的应用 | |
CN103251611A (zh) | Aspeverin在制备抗细菌药物中的应用 | |
CN103263428A (zh) | Polyflavanostilbene A在制备抗结核菌药物中的应用 | |
Ateshim et al. | Evaluation of antimicrobial activity and phytochemical screening of Silene macrosolen and Solanum incanum: A common medicinal plant in Eritrea | |
CN106491616A (zh) | Friedolanostanes在制备抗结核菌药物中的应用 | |
CN105497008A (zh) | Spirooliganone A在制备治疗抗结核菌药物中的应用 | |
Etsuyankpa et al. | The antibacterial activity and some trace elemental compositions of the extracts of Pilistigma thonningii, a widely used ethnomedicinal tree in Minna, Nigeria. | |
Soundhararajan et al. | Multidrug-resistant Bacillus species isolated from hospital soil environment is controlled by nanobiotics incorporated nanoformulation | |
CN103463012A (zh) | Fluevirosines A在制备治疗抗结核菌药物中的应用 | |
CN105380938A (zh) | Isocycloartobiloxanthone在制备治疗抗结核菌药物中的应用 | |
CN103446145B (zh) | Lycojaponicumin C在制备抗结核菌药物中的应用 | |
CN105232520A (zh) | Linderolide G在制备治疗抗结核菌药物中的应用 | |
CN103462976B (zh) | Incarviatone A在制备抗结核菌药物中的应用 | |
CN103479631B (zh) | Lycojaponicumin B在制备抗结核菌药物中的应用 | |
CN105496998A (zh) | Vulgarisin A在制备治疗抗结核菌药物中的应用 | |
CN103446129B (zh) | Lycojaponicumin A在制备抗结核菌药物中的应用 | |
Alnakhli et al. | Thymus Algeriensis and Artemisia Herba-Alba Essential Oils: Cytotoxicity, Antibacterial and Antifungal Activities and Subacute Toxicity | |
Pandey et al. | Novel Therapeutics: A Nemesis for Biofilm-forming Mycobacterium spp. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Zhang Hongwei Inventor after: Ding Yinhuan Inventor after: Zhou Pan Inventor after: Han Yunwei Inventor after: Yang Qinglong Inventor before: Li Yang |
|
CB03 | Change of inventor or designer information | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20180202 Address after: 646000 Luzhou province Sichuan City Jiangyang District Taiping Street No. 25 Applicant after: THE AFFILIATED HOSPITAL OF SOUTHWEST MEDICAL UNIVERSITY Address before: Lishui Economic Development Zone Nanjing City, Jiangsu province 211215 zhe Ning Road No. 1 Applicant before: The wide informational inquiry centre of Nanjing China |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20180313 Termination date: 20180811 |
|
CF01 | Termination of patent right due to non-payment of annual fee |